ACH-0141625
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ACH-0141625, covering 2014-09-10 to 2014-09-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants [Phase 2]